C
Fonar Corporation FONR
$18.41 $0.070.38% NASDAQ
Recommendation
Dividend Power Score
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
EPS (TTM)

Company Overview

Fonar Corporation is a U.S.-based medical technology company that designs, manufactures, markets, and services magnetic resonance imaging (MRI) systems, with a primary focus on its proprietary Upright MRI technology. The company operates within the medical imaging and diagnostic healthcare equipment industries, serving hospitals, diagnostic imaging centers, and physician practices. Its core differentiation lies in MRI systems that allow patients to be scanned in weight-bearing positions, which the company asserts can reveal conditions not always visible in conventional recumbent MRI scans.

Founded in 1978, Fonar is recognized as the first company to manufacture and commercialize MRI scanners. The company was established by physicist Raymond Damadian, a pioneer in MRI technology. Over time, Fonar evolved from a pure equipment manufacturer into a hybrid model that combines system sales with recurring revenue from diagnostic imaging center management, reflecting a strategic shift toward more stable cash flows and operational control of imaging services.

Business Operations

Fonar operates through two primary business segments: MRI Systems and Diagnostic Imaging Management Services. The MRI Systems segment encompasses the design, manufacture, sale, installation, and servicing of MRI scanners, including Upright and conventional configurations, as well as related upgrades and maintenance contracts. Revenue in this segment is driven by equipment sales and long-term service agreements.

The Diagnostic Imaging Management Services segment generates revenue by managing and operating MRI facilities, primarily through wholly owned subsidiaries. This segment includes billing, staffing, compliance, and day-to-day operational oversight of imaging centers, and represents the majority of the company’s recurring revenue. Operations are concentrated in the United States, and the company relies on internally developed MRI technology rather than licensed third-party platforms.

Strategic Position & Investments

Fonar’s strategic direction emphasizes leveraging its proprietary Upright MRI technology while expanding its managed services footprint to stabilize revenues and mitigate the cyclical nature of capital equipment sales. Growth initiatives have historically focused on expanding the number of imaging centers under management rather than aggressive international expansion or large-scale acquisitions.

The company’s investment strategy has primarily involved internal capital deployment into imaging center operations and incremental enhancements to its MRI technology. Fonar does not maintain a broad portfolio of unrelated investments and has limited exposure to emerging technologies outside MRI. Public disclosures indicate no material reliance on joint ventures, and acquisitions have been selective and directly tied to expanding or consolidating diagnostic imaging operations.

Geographic Footprint

Fonar’s operations are predominantly concentrated in North America, with its corporate headquarters located in New York, United States. The majority of its managed diagnostic imaging centers and installed MRI systems are located across multiple U.S. states, reflecting a domestic operational focus.

Internationally, Fonar has historically marketed MRI systems in select foreign markets; however, international sales and operations represent a limited portion of overall revenue. The company does not report a significant operational presence or manufacturing footprint outside the United States, and its global influence is primarily technological rather than geographic.

Leadership & Governance

Fonar’s leadership structure reflects its founder-led origins and long-term continuity in executive management. Strategic vision has historically emphasized technological differentiation in MRI imaging and vertical integration through imaging center management. Governance is overseen by a board that includes executive leadership and independent directors, consistent with public company requirements.

Key executives include:

  • Timothy Damadian – President and Chief Executive Officer
  • Raymond Damadian – Founder and Chairman

Publicly available disclosures consistently identify these leaders; however, information regarding additional senior executives varies across reporting periods. Data inconclusive based on available public sources regarding the current composition of other named executive officers.

Data complied by narrative technology. May contain errors

Top Tech Stocks
See All »
B
NVDA NASDAQ $175.20
B
AAPL NASDAQ $251.64
B
MSFT NASDAQ $372.74
Top Consumer Staple Stocks
See All »
B
WMT NASDAQ $122.05
B
Top Financial Stocks
See All »
B
B
JPM NYSE $292.40
B
V NYSE $303.76
Top Energy Stocks
See All »
B
ENB.TO TSX $73.47
B
ENB NYSE $54.44
Top Health Care Stocks
See All »
B
LLY NYSE $903.02
B
JNJ NYSE $235.27
B
AMGN NASDAQ $348.43
Top Real Estate Stocks
See All »
B
PLD NYSE $130.35